关键信息
-
基因名
BDLF3
- 应用
-
别名
BDLF3；
-
种属
Epstein-Barr
-
表达系统
E. coli
-
标签
His tag N-Terminus
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
P03224
-
表达区间
29-186aa
-
氨基酸序列
SSTASAGNVTGTTAVTTPSPSASGPSTNQSTTLTTTSAPITTTAILSTNTTTVTFTGTTVTPVPTTSNASTINVTTKVTAQNITATEAGTGTSTGVTSNVTTRSSSTTSATTRITNATTLAPTLSSKGTSNATKTTAELPTVPDERQPSLSYGLPLWT
-
分子量
22.7 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
质检流程
相关产品
背景信息
BDLF3 is a critical protein encoded by the Epstein-Barr virus (EBV), which belongs to the herpesvirus family. This virus is known for its role in various human diseases, including infectious mononucleosis and certain malignancies, such as Hodgkin lymphoma and nasopharyngeal carcinoma. The BDLF3 protein is involved in viral replication and the modulation of host immune responses, acting as an important factor in the virus's ability to establish latency and promote persistent infection. Understanding the structure and function of BDLF3 is crucial for deciphering its role in the viral life cycle and devising potential therapeutic strategies. Recent studies have focused on characterizing the recombinant BDLF3 protein, aiming to elucidate its interactions with host cellular mechanisms, particularly in immune evasion and signaling pathways. Advances in protein expression techniques have enabled the production of BDLF3 in significant amounts, facilitating biochemical and structural analyses. Insights gained from these studies may contribute to the development of targeted antiviral therapies and vaccines, highlighting the importance of BDLF3 in the broader context of EBV-associated diseases.
